HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lynn Jackson Selected Research

2- (1- (2- (2,3- dihydro- 1- benzofuran- 5- yl)ethyl)piperidin- 3- yl)- 2,2- diphenylacetamide

10/2007Identification and characterization of UK-201844, a novel inhibitor that interferes with human immunodeficiency virus type 1 gp160 processing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lynn Jackson Research Topics

Disease

2Tuberculosis (Tuberculoses)
01/2015 - 01/2015
2Extensively Drug-Resistant Tuberculosis
01/2015 - 03/2014
2Infections
01/2015 - 10/2007
1Vesicular Stomatitis
10/2007

Drug/Important Bio-Agent (IBA)

2Pharmaceutical PreparationsIBA
01/2015 - 03/2014
1NucleotidesIBA
01/2015
12- (1- (2- (2,3- dihydro- 1- benzofuran- 5- yl)ethyl)piperidin- 3- yl)- 2,2- diphenylacetamideIBA
10/2007
1Glycoproteins (Glycoprotein)IBA
10/2007